An Exploratory Study of Personalized Cancer Vaccine in Adjuvant Therapy of Solid Tumors

NCT07680582 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Solid Tumor

Interventions

DRUG: ABO2109 Injection
DRUG: Toripalimab

Sponsor

Ruijin Hospital

Collaborators

[object Object]
[object Object]